Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zoledronate vs Clodronate vs Ibandronate in Primary Breast Cancer
NCT00127205Phase 3Completed
- Sponsor
- SWOG Cancer Research Network
- Start
- Jul 2005
- Primary completion
- Dec 2017
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of zoledronic acid in breast cancer, sponsored by SWOG Cancer Research Network. Started Jul 2005; status: completed.
02
Drugs
zoledronic acid
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00127205.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00127205.